CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Up 35.2% in January

CanSino Biologics Inc. (OTCMKTS:CASBF) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 14,600 shares, an increase of 35.2% from the December 31st total of 10,800 shares. Based on an average daily volume of 1,100 shares, the short-interest ratio is currently 13.3 days.

CanSino Biologics Price Performance

Shares of CanSino Biologics stock remained flat at C$3.37 during mid-day trading on Friday. CanSino Biologics has a 1 year low of C$1.86 and a 1 year high of C$4.35. The company has a fifty day simple moving average of C$3.79 and a 200-day simple moving average of C$3.20.

About CanSino Biologics

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.